Visit http://www.otcpicks.com to register for our Daily Market Mover's Digest Newsletter and Email Stock Watch Alerts.
MONOGRAM ENERGY INCORPORATED (OTC: MGRN | news | PowerRating | PR Charts ) "Up 14.29% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MGRN.php
Company Profile: http://www.otcpicks.com/monogram-energy/monogram-energy.htm Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.
MGRN News:
May 13 - Monogram Energy Inc. Continues to Produce in Corsicana, Texas
Monogram Energy, Inc. (OTC: MGRN), an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties, announced that the Company will begin workovers on 3 additional wells early next week in Corsicana, Texas. These wells are part of the T.W. Martin lease and are expected to produce an estimated 270 barrels a month. The workover is expected to take one week to complete and will increase the total number of wells in production to eight. The T.W. Martin lease comprises 70 acres with 12 wells and is located in Navarro County, which produces around 600,000 barrels annually.
"These next three wells should provide us with some nice operating cash flow," stated Mr. Billy King, Chief Executive Officer of Monogram Energy, Inc. Mr. King became interested in the production of oil & gas during his ten years of employment as an attorney for the Halliburton Company, and with his representation of independent oil companies during his years as a private practitioner. Monogram Energy's goal is to maintain a high risk/reward profile, thereby enabling them to return the most value to its shareholders.
IOMAI CORPORATION (NASD: IOMI | news | PowerRating | PR Charts ) "Up 116.10% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/IOMI.php
Iomai Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of vaccines and immune system stimulants delivered to the skin through a needle-free technology called transcutaneous immunization or TCI. The TCI technology is designed to trigger an immune response by targeting Langerhans cells. The company's products under development include IS patch for pandemic flu program, a Phase I clinical trial IS patch that, when used in conjunction with an injectable flu vaccine, is designed to stimulate an immune response, as well as that allows public health officials to extend vaccine supply in the event of an influenza pandemic; and IS patch for elderly receiving flu vaccines, a Phase II clinical trial IS patch to improve the immune response of the elderly to existing injectable influenza vaccines. The company also develops a needle-free flu vaccine patch, a Phase I clinical trial product candidate, which combines flu antigens with an adjuvant in a single patch; a needle-free pandemic flu vaccine patch, a product candidate under preclinical development, which combines pandemic flu antigen with an adjuvant in a single patch to solve issues regarding mass vaccination in the event of an outbreak of pandemic flu; and a needle-free travelers' diarrhea vaccine patch, a Phase II clinical trial product candidate, which is designed to induce a immune response that diminished the severity and delayed the onset of the common form of travelers' diarrhea. The company was incorporated in 1997 and is based in Gaithersburg, Maryland.
IOMI News:
May 12 - Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
Intercell AG (VSE: ICLL) and Iomai Corporation (NASD: IOMI | news | PowerRating | PR Charts ) announced that they have entered into a definitive agreement pursuant to which Intercell will acquire Iomai for USD 6.60 per share representing a fully diluted equity value of approximately USD 189 million (EUR 122 million). The transaction has been unanimously approved by the Boards of Directors of both companies and is subject to customary closing conditions including antitrust clearances, clearance by the Committee on Foreign Investment in the United States and the approval of the holders of a majority of Iomai's shares. Shareholders holding over 50 percent of Iomai's total shares outstanding have entered into agreements to vote in favour of the combination.
Intercell will gain full rights to Iomai's late stage Travelers' Diarrhea vaccine which is based on Iomai's proprietary needle-free patch delivery vaccine technology and has shown positive interim Phase II efficacy data. The Travelers' Diarrhea vaccine is expected to enter pivotal Phase III trials in the first half of 2009. If approved, the medical use of Iomai's Travelers' Diarrhea vaccine will be highly complementary with Intercell's Japanese Encephalitis vaccine for which a Biologics License Application was successfully submitted to the US Food and Drug Administration in December 2007, and for which Intercell expects market approvals in the US, Europe and Australia in 2008. Together, both vaccines create an extremely attractive Traveler's Vaccine franchise which will target a combined market opportunity of over USD 1 billion in sales per year.
Commenting on the transaction, Gerd Zettlmeissl, CEO of Intercell, said: "This transaction further expands our leadership in vaccine innovation, greatly enhances Intercell's R&D technology base and further strengthens our late stage vaccine portfolio. Building on our proven experience in industrialization and in moving novel products to the market, Intercell is fully committed to becoming the leading pure play vaccine company globally. We look forward to welcoming Iomai's employees to Intercell and are excited by the potential of the combined group to create significant value for all stakeholders."
Stanley C. Erck, President and CEO of Iomai, said: "We have built a dynamic and scientifically driven organisation. This strategic combination with Intercell will create a stronger, more diversified vaccine company and will accelerate the development of Iomai's vaccine programs and fully leverage our innovative TCI technology. We believe this transaction is in the best interest of all parties, including shareholders, employees and ultimately patients."
Intercell will also gain full rights to two additional clinical and three preclinical programs under development, the most advanced being an immunostimulant vaccine patch in Phase II for pandemic influenza. This patch is designed to enhance the immune response compared to injected pandemic influenza vaccines. If successful, it would have the effect of expanding limited vaccine supplies by allowing public health officials to use fewer or lower doses of the vaccine. The vaccine patch has recently generated positive interim immunogenicity data in a 500-subject Phase I/II study with a one-dose application. The program is funded by a grant from the United States Department of Health and Human Services.
Iomai's pioneering work in transcutaneous immunization (TCI) technology has led to the development of a simple and promising needle-free vaccine patch. This highly innovative vaccine delivery system provides a potential future alternative to current injected vaccines. TCI technology has the potential to enhance the efficacy of existing vaccines, replace current vaccines that have a cumbersome mode of administration and enable the development of new vaccines that are not viable to be delivered via an injection.
Iomai's TCI technology strengthens Intercell's position as an innovative vaccine company and is highly complementary with its proprietary antigen identification and adjuvant vaccine technology platforms (AIP and IC31 ). TCI adds an important third arm to Intercell's leading vaccine technologies, specifically a delivery platform for antigens and adjuvants that can facilitate the development of a broad range of in-house and partnered vaccine products. Both companies have already partnered technologies with Merck & Co., Inc., the most recent one being Iomai's agreement to conduct proof-of-principle preclinical studies evaluating the use of its needle-free immunostimulant patch. Intercell plans to further leverage the TCI technology by applying it to other vaccines in its development pipeline, such as its Pneumococcus vaccine candidate.
Furthermore, Iomai's vaccine patch has the potential to provide cheaper and more effective medication to those living in endemic areas, in particular high risk groups such as children and the elderly located in developing countries in Africa, Asia and Latin America.
Transaction Terms:
Under the terms of the merger agreement, Intercell will acquire Iomai for USD 6.60 per share of Iomai's common stock representing a fully diluted equity value of Iomai of approximately USD 189 million (EUR 122 million). The consideration will be paid in cash and stock. Iomai's public shareholders, representing approximately 59 percent of Iomai's outstanding common stock will receive cash. Certain of Iomai's largest shareholders, together representing approximately 41 percent of Iomai's outstanding common stock, have agreed to exchange their shares for Intercell stock at an exchange ratio corresponding to a value of USD 6.60 per share of Iomai common stock upon closing.
The combination is structured as a share exchange together with a merger of Iomai and a US subsidiary of Intercell. Certain of Iomai's largest shareholders (and their affiliates), which together represent over 50 percent of Iomai's outstanding common stock, have agreed pursuant to a voting agreement with Intercell that they will vote their shares in favour of the merger.
The transaction has been unanimously approved by the Boards of Directors of both companies and is subject to customary closing conditions, including the approval of the merger by a majority of shareholders of Iomai at a special shareholder meeting to be held as soon as practical, receipt of antitrust clearances and clearance by the Committee on Foreign Investment in the United States. Intercell and Iomai expect the transaction to close before the end of the third quarter of 2008.
Based on Intercell's closing share price as of 9 May 2008, Intercell would issue approximately 1.7 million Intercell shares from authorized capital as consideration, the final number of Intercell shares to be determined shortly before the closing of the transaction. Intercell will fund the cash component of the transaction from existing cash reserves and expects to maintain profitability in 2008.
Merrill Lynch International acted as exclusive financial adviser to Intercell and Cowen and Company provided a financial fairness opinion to Iomai's Board of Directors.
ACTIONVIEW INTERNATIONAL INCORPORATED (OTCBB: AVWI | news | PowerRating | PR Charts ) "Up 50.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/AVWI.php
ActionView International's operating subsidiary custom-designs, develops, and manufactures vividly illuminated motion billboards. ActionView places its signs into high traffic locations and markets advertising space on the signs. ActionView shares advertising revenue generated from the billboards with advertising agencies, the local business partner and the location owner. The benefit to advertisers is exposure in high traffic locations at reasonable costs due to the scrolling feature and multiple advertisers. For additional information about ActionView, visit www.actionviewinternational.com.
AVWI News:
May 12 - ActionView International, Inc. Announces Letter of Intent for Acquisition Transaction With Jim Palmer Trucking, Inc.
ActionView International, Inc. (OTCBB: AVWI | news | PowerRating | PR Charts ) announced that the company has entered into an initial agreement in the form of a letter of intent for an acquisition transaction with Jim Palmer Trucking, Inc., a leading transportation company headquartered in Missoula, Montana. Jim Palmer Trucking was established in 1966 with one truck and has grown into one of the premier refrigerated carriers in the United States. Jim Palmer Trucking operates in 44 states and maintains a fleet of 350 trucks and 500 trailers.
Jim Palmer Trucking's top five customers by percentage of revenues include Anheuser Busch, the Kroger Co., Coors Brewing Company, C.H. Robinson Worldwide, and Tyson Foods. In addition to its headquarters in Missoula, Montana, Jim Palmer Trucking has terminals in Salina, Kansas and Denver, Colorado. Jim Palmer Trucking also has drop lots located in Fontana, California; Tampa, Florida; Portland, Oregon; Wenatchee, Washington; and Chicago, Illinois.
The initial agreement in the form of a letter of intent provides the framework for a subsequent definitive agreement under which ActionView International would acquire all of the issued and outstanding shares of Jim Palmer Trucking, Inc. in exchange for a majority percentage of ActionView International. The details of the proposed share exchange will be included in the definitive agreement.
The letter of intent outlines additional due diligence, audit work and other terms that must be fulfilled to proceed to definitive agreement and to subsequently effect a close of the transaction.
The post merger plan for Jim Palmer Trucking includes a potential acquisition strategy, the addition of new members to the management team, and the development of additional business lines within the trucking industry while maintaining and growing existing accounts in its core business.
"Jim Palmer Trucking is a mature company with substantial revenues and a solid strategy for additional future growth, and we are extremely pleased to have reached an initial agreement for an acquisition transaction," stated Steven R. Peacock, president/chief executive officer of ActionView International. "We look forward to the completion of the ongoing due diligence and moving to a definitive agreement with Jim Palmer Trucking once the terms of the letter of intent have been met."
HIDALGO MINING INTERNATIONAL (OTC: HMIT | news | PowerRating | PR Charts ) "Up 19.05% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/HMIT.php
Hidalgo Mining International (OTC: HMIT), an innovative mining company headquartered in Port Washington, NY, strives to increase shareholder value, while implementing aggressive plans to continue targeting near term mining production projects on a global scale. HMIT's management, directors, and advisors hold an abundance of experience and knowledge to implement expansion in this rapidly growing industry.
HMIT News:
May 13 - Hidalgo Mining International (HMIT) Announces LOI Signed to Acquire Fifa Mining Inc.
Hidalgo Mining International (OTC: HMIT), an innovative mining company headquartered in Port Washington, NY, announced today that it has signed an LOI to acquire Fifa Mining Inc. Fifa holds key assets, including the mining rights to the Fifa project in Guinea, West Africa within the Siguiri Basin.
Mark Daniel Klok, President of HMIT, stated: "The Company has entered an agreement with Fifa Mining Inc. to begin producing on the Fifa land prospecting permit. The permit, located in the northwest corner of the Siguiri Basin, is approximately 88 kilometers west of the town of Siguiri and approximately 65 kilometers west of the Siguiri Gold Mine Operation that is currently owned and operated by AngloGold Ashanti. This agreement consists of a 60-day due diligence period, during which Hidalgo shall commence production on the property. We are very familiar with this property and the associated permit and therefore anticipate confirmation of feasibility, through actual production, well within the 60-day period. Consummation of this acquisition would be an enormous step towards our goal of becoming a world-class junior mining company."
ABOUT THE FIFA PROPERTY
The Fifa permit area is underlain by finely stratified siltites, argillites, and minor feldspathic sandstones, typical of continental marine platform deposits. Most of the Siguiri Basin is almost entirely covered with laterite duricrust plateaus, pediments, and recent alluvial deposits. Outcrops are rare and mostly saprolitic in nature.
Immediately south of the Fifa permit area the pelitic sequences are cut by lenses and larger bodies of monzogranite and granodiorite and are of the type recognized throughout the Siguiri Basin. Altered and weathered cobbles of a fine to medium grain rock of basic composition (diabase) have also been observed in the area. The ductile deformation affecting the sedimentary sequences is along a general north-northeast axis. The linear pattern of some of the streams draining towards the Tinkisso River in and around the area suggests that north-northeast to north-south and east-northeast to north-northeast structures have affected the rocks. The various orientations of quartz veins and some of the ridges observed on the projects and elsewhere are concordant with these orientations. Evidence of hydrothermal activity is obvious on the projects where extensive quartz veining and kaolinite alteration is pervasive.
The free gold recovered from the alluvial deposits on the permit area finds its source in the country rocks. Reconnaissance prospecting and soil sampling around the village of Fifa have highlighted the potential of the permit, for both lateritic type and primary gold deposits.
Several quartz veins related to hydrothermal activities, often associated with gold mineralization, have been found on the permit. Pits and a trench have been excavated to properly sample one of the veins located south of the village of Fifa. The trench revealed that the vein is part of an extensive hydrothermal veining system similar to the one hosting some of the gold deposits at the nearby Siguiri gold mine. Sampling in this trench returned anomalous gold concentration in the altered wall rocks. The highest value obtained was 13.4 grams of gold per ton over a 60-centimeter section of the trench.
ABOUT THE EXPLORATION CONDUCTED BY HAMILTON MINING & MARKETING
Between June 2002 and July 2007 HMM maintained a prospecting crew in the Fifa land prospecting permit area with the objective of testing the land potential for economic gold deposits in the alluvial deposits and laterite formations. The fieldwork program, consisting of pitting, soil sampling, and trenching, was carried out mainly west and south of the village of Fifa in the eastern section of the permit area. During this time HMM outlined four blocks where previous local mining activity had taken place within the Fifa land prospecting permit area: Kolen-Jima, Kele-Lolou, Siguiri-Sila and Kabine-Bee. HMM estimated that the four areas have a first resource estimate of 488 kilograms (approximately 15,700 ounces) of recoverable gold. A first conservative estimate based on the data available to date and assuming that 50% of the original ore remains on site, inferred that a resource of 1,000 kilograms (approximately 32,000 ounces) of gold could be recovered from the four blocks. A preliminary prospecting program for alluvial gold deposits was carried out on these four blocks. A total of 28 prospecting pits in the alluvial deposits of the Bereko River were excavated. The Kabine-Bee block, located 4.1 kilometers north of Fifa where the alluvial flat of the Bereko River narrows, has been extensively exploited by past artisan operations for at least 500 meters along the course of the river. Along one line, three prospecting pits were excavated at 100-meter spacings. The basal gravel composed of sub-rounded quartz cobbles with minor amounts of pisolitic pebbles in a brownish sandy quartz matrix was reached at depths ranging from 5.6 meters to 9.44 meters under an upward sequence of sand, silt and clay overburden. The thickness of the gravel ranged between 0.27 and 1.16 meters and the calculated grades ranged between 0.2 to 1.97 grams per cubic meter.
At the Kele-Lolou block, located east of Fifa, a single pit was excavated on the edge of a large alluvial mining field. The gravel was 1.90 meters thick, but the recovered grade was 0.4 grams per cubic meter.
At the Siguiri-Sila block, approximately 2.0 kilometers south of Fifa, 14 pits on four lines were completed over an area of about 300 cubic meters that was untouched by the local miners. The average depth to saprolitic bedrock over the area ranged between 5.0 to 9.0 meters with a basal gravel ranging in thickness between 0.5 to 2.0 meters and had a recovered grade range between trace to 7.37 grams per cubic meter with an average grade of 2.18 grams per cubic meter. These results are considered significant and of economic interest, but additional prospecting will be necessary to outline larger volumes of gravel with similar grades to justify an eventual mechanized operation.
During the prospecting program, several areas with outcropping quartz veins were identified in the eastern portion of the Fifa land prospecting permit area. The veins often formed positive relief and outcrop along the flanks of ridges and hills above the edge of the pediment deposits. The thickness of the veins ranges from 40 centimeters to approximately 1.0 meter. Five of these veins were sampled. Results showed gold content varying from less than 10 parts per billion gold to 250 parts per billion gold. Two samples revealed concentrations of 1.3 grams of gold per ton over 0.5 meters and 9.5 grams of gold per ton over 0.7 meters.
HMM also carried out prospecting for gold in eluvial deposits. During the course of HMM's program approximately 500 soil samples were collected at 100 meter spacings from the eluvial deposits and adjoining saprolitic zones over an area covering approximately 19.25 square kilometers and extending along the west bank of the Bereko River and south of Fifa. In the southeast corner of the grid, following the emergence of a significant anomalous area (up to 1,249 parts per billion gold) the sampling grid was reduced to 50 meters around the anomalous sample area. The overall average gold concentration for the entire sample population available was 5.0 parts per billion gold including samples with gold concentration below detection limits of the analytical method of 10 parts per billion gold. Excluding these samples, the average concentration was 139 parts per billion gold with 78% of the samples with concentrations between 10 and 130 parts per billion gold. Gold in soil anomalies were found in each of the sampling grids and were forming relatively scattered but persistent northeast to north-northeast trending zones. These anomalous zones are continuous for several meters along strike.
TRANSFERORBIT CORPORATION (OTC: TRBI | news | PowerRating | PR Charts ) "Up 35.29% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/TRBI.php
TransferOrbit Corporation operates as an electronic processor for money transfer providers in the United States. Banking institutions and related businesses throughout the United States utilize TransferOrbit's proprietary system of secure network processing software to facilitate person-to-person money transfers to Central and South America, including Mexico. This turnkey, private-label system gives US-based providers valuable access to the Company's vast, established network throughout Latin America. The market advantages of TransferOrbit's system are: (1) a greater selection of destination points; (2) modern Web-based and plug-in technologies; (3) a 100% scalable system that is compatible with most traditional infrastructures; and (4) a system that is 100% compliant with all current applicable laws and standards.
TRBI News:
May 13 - Lucky Money Expands Successful Money Transfer Services to Latin American Markets Through Agreement with TransferOrbit
TransferOrbit Corporation (OTC: TRBI | news | PowerRating | PR Charts ) has been contracted by San Francisco-based Lucky Money, Inc. to provide money transfer services to TransferOrbit's 17,000 destination agents located throughout Latin America.
Lucky Money, which was founded in 1991 to serve the money transfer needs of the Filipino market, is a family owned business that has always focused on customer satisfaction and high quality service. Having experienced steady, significant growth servicing the money transfer needs of Asian Americans, Lucky Money is excited to add TransferOrbit's network and processing abilities to its service model. This arrangement will position Luck Money to gain a piece of the lucrative and expanding Latin America money transfer market.
The alliance between the two parties will add 84 new money transfer locations to TransferOrbit's origination network of licensed agents located in California, Florida, Illinois, New Jersey, Nevada, Washington, Virginia and Texas. The contract also includes servicing Lucky Money's very successful Web-based money transfer business, located at www.luckymoney.com.
As part of the Lucky Group of Companies (www.luckycompanies.com), Lucky Money's goals state that the Company's main priority in the ever-changing global transfer marketplace is meeting the specific needs of its growing customer base. Ruell Medina, COO of Lucky Money, stated that, "Having gained the trust and confidence of our existing client base, we have decided the time was right to broaden our reach and provide the same fast, secure and reliable remittance services to the Latin American community."
"We are enthusiastic about the growth potential of this partnership," commented Jorge Toro, President and CEO of TransferOrbit. "Our alliance with Lucky Money adds substantial volume to our network." TransferOrbit has disclosed a series of key alliances since it transitioned into the public market at the beginning of 2008. Mr. Toro added, "Conservatively speaking, this alliance should add $12 million in gross sales of foreign exchange to our financials next year."
ABOUT LUCKY MONEY, INC.
Founded in 1991, Lucky Money, Inc. is one of the country's leading money remittance providers to the Philippines. Operating over 100 locations worldwide through company owned branches and approved agents; Lucky Money is licensed in 13 states. The company offers convenient and reliable money remittance through its physical office locations as well as its online remittance website at www.luckymoney.com.
ABOUT OTCPICKS.COM
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.
Release of Liability:Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has received fifty thousand free trading shares from a non-controlling third party (Microcap Management) for MGRN advertising and promotional services. For a complete list of disclosures go to http://www.otcpicks.com/disclosure_details.php. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.
The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.
Third Party Web Sites and Information:
OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
CONTACT: Brian Dean, Publisher, OTCPicks.com Tel: +1 972 546 3740 e-mail: publisher@otcpicks.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index